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small risk of PE, the practice of more limited and selective
AC to treat UEDVT seems warranted.
Table. Comparison of patient andUEDVT characteristics
among anticoagulated and nonanticoagulated patients
Patient/DVT characteristic AC () AC (-) P value
Patient age 48/-18 54/-17 .002a
Death at 3 months 26/107 (13%) 51/193 (26%) .001b
UEDVT associated PE 11/207 (5%) 2/193 (1%) .02b
# named DVT segments 2.1/-1.2 1.7/-1.0 .001b
Acute DVT component 185/207 (89%) 148/193 (77%) .001b
at-test;
bChi-square
Author Disclosures: F. C. Albuquerque: Nothing to
disclose; M. F. Amendola: Nothing to disclose; D. R.
Brinster: Nothing to disclose; M. M. Levy: Nothing to
disclose; J. Pfeifer: Nothing to disclose.
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Objectives: Early postoperative ambulation prevents
deep vein thrombosis (DVT) by enhancing lower extremity
(LE) venous flow. Postoperative patients may require pro-
longed bed-rest. We tested if upper body exercise (UBE)
increased LE venous flow, as a potential means for prevent-
ing DVT.
Methods: 15 healthy volunteers (20-40 yrs) performed
4 low-intensity (5watts, 75rpm) UBE protocols on an
ergometer (single 30-sec and 3-min UBE bouts; and 3
repetitions of 30-sec and 3-min bouts with 1 min rest
between bouts). External iliac vein volume flow was mea-
sured by ultrasound before and after UBE.
Results: A single 30-sec bout of UBE increased LE
volume flow by 39%; the increase was maintained up to 10
mins post-exercise (P .05). A single 3-min bout of UBE
increased flow by 23% (P  .05); flow was elevated (19%)
for 5 mins (P .07). With 3 repetitions of the 30-sec UBE
bouts, flow increased 57% after 1 bout and remained34%
higher after the remaining bouts for a total of 8.5 min of
increased venous flow (P .05, Fig). With repeated 3-min
UBE, flow increased 32% after 1 bout, and remained21%
higher after the remaining bouts for an additional 5 mins
(P .05).
Conclusions: We report a novel finding that UBE
increases LE venous blood flow. The effect is consistent and
durable. Three 30-sec bouts of low-intensity UBE was the
most effective; eliciting a net increase of 4.5L of LE
venous flow over8.5 minutes. UBEmay be an alternative
for prophylaxis of DVT in patients with restricted ambula-
tion.
Venous volume flow in the lower extremity after upper
body exercise (3 bouts of 30-seconds ergometry).
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Objectives: Instruments to evaluate outcomes post VV
treatments mix symptoms/signs and health-related quality
of life. In contrast, the VV Symptoms Questionnaire
(VVSymQ™), a patient-reported outcome instrument de-
veloped using iterative qualitative interviews with patients,
considers only symptoms. To evaluate feasibility, reliability
and validity of the VVSymQ™ via a PDA for measure of VV
symptoms before and after great saphenous vein (GSV)
closure (immediately preceding wk 8 visit) and to estimate
treatment effect size (ES), the VVSymQ™ was adminis-
tered daily using a PDA 14 days pre  10 days post GSV
closure.
Methods: VVSymQ™ assessed duration and intensity
(6 and 11 point scales) of the 5 most important VV symp-
toms. Feasibility was evaluated by compliance; reliability by
agreement between 1st and 2nd 7-day pre-GSV closure
scores; and validity by correlation with other instruments:
PA-VA3, VCSS, VEINES QoL, CIVIQ-20.
Fig.
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Results: 40 patients were recruited (mean age 49.7;
62% female). Compliance with daily diary completion was
97%. Symptom scores remained stable for 14 days pretreat-
ment and symptom score fell by 80% post GSV closure. ES
(mean change/SD) and correlations with other instru-
ments are shown in Table.
Conclusions: VVSymQ™ is a simple patient-centered
measure that can be administered daily via a PDA with very
high compliance. It is sensitive to clinically important
symptom improvements following GSV closure and corre-
lates with existing instruments.
ES and correlation between instruments pre and post
GSV closure
Table.
VVSymQ PA-V3 VCSS
VEINES-
QoL
CIVIQ-
20
Effect size (ES) 2.0 (paper) 1.6
(electronic)
1.5 3.4 1.8 1.2
Correlation
pre-GSV
closure
– 0.318a NS 0.727c 0.518c
Correlation 8
week post-
GSV closure
– NS 0.456b 0.755c 0.587c
aP.05;
bP.01;
cP.001; NSnot significant
Author Disclosures: G. Bate: Nothing to disclose; A.
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Objectives: Endovenous ablation of the great and
small saphenous veins has become the standard surgical
therapy for the treatment of chronic venous insufficiency
(CVI). Vein recanalization following radiofrequency abla-
tion (RFA) has been described. This study reviewed the
incidence of and risk factors for developing recanalization
after successful ablation.
Methods: This two-center retrospective study re-
viewed 249 limbs that underwent RFA of either the great
(GSV) or small saphenous vein (SSV) over a three-year
period, and for which an intermediate duplex ultrasound
was available. All cases of saphenous recanalization (N16,
6.4%), were identified and the associated patient data,
including comorbidities and need for additional interven-
tions, were analyzed.
Results: Seventeen limbs demonstrated either seg-
mental (9, 53%) or complete (8, 47%) recanalization of
the GSV after initial successful ablation. Recanalization
was associated with higher rate of symptom recurrence
(41% v 21%, RR 2.75, 95% CI, 0.99-7.6) and need for a
second vein procedure in the affected limb (35% v 12%,
RR 3.96, 95% CI 1.3-11.7). Two GSVs required a
second endovenous ablation for persistent venous ulcers.
Concomitant diabetes, hyperlipidemia, anticoagulation
use, antiplatelet use, presence of deep reflux, or tobacco
use did not increase the risk of recanalization. Compar-
atively, patients with GSV recanalization had a longer
mean follow-up (63.3 v. 41.6 weeks) but no difference in
disease severity (C4, 35% v. 17%; C5, 18% v. 15%; C6, 6%
v. 8%, NS).
Conclusions: GSV recanalization following RFA for
the treatment of CVI appears to be a sporadic phenomenon
without clearly associated risk factors. Recanalization, al-
though often involving an isolated segment of the great
saphenous vein, is associated with a two-fold increase in
symptom recurrence and the need for interval vein proce-
dures. Follow-up ultrasound interrogation is recom-
mended especially in patients with persistent or recurrent
symptoms or ulceration.
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Calf Deep Vein Thrombosis: Current Trends in Man-
agement
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Objectives: Deep vein thrombosis (DVT) involving
calf veins is relatively common condition with an incidence
of almost 2% in the general population. Despite this high
incidence there is lack of consensus regarding appropriate
management of the condition borne primarily from paucity
of evidence. Our objective as a prelude to a larger random-
ized trial was to review current management practices by
means of a national survey.
Methods: The survey was conducted among vascular
specialists who routinely manage patients with calf DVT.
This was done by means of a 19 point questionnaire. The
110 responses accrued were collated and analyzed to ascer-
tain practice patterns.
Results: Of the 110 practitioners 68 (62%) were Vas-
cular Surgeons. Amongst the responders, while 93 (85%)
would anticoagulate for axial calf vein DVT, only 60 (55%)
would anticoagulate for muscular calf vein DVT. Of those
practitioners anticoagulating for calf DVT 60% would fol-
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